Xingkang Wu

556 total citations
40 papers, 444 citations indexed

About

Xingkang Wu is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, Xingkang Wu has authored 40 papers receiving a total of 444 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 7 papers in Pharmacology and 7 papers in Oncology. Recurrent topics in Xingkang Wu's work include Cancer therapeutics and mechanisms (9 papers), Bioactive Compounds and Antitumor Agents (7 papers) and Microbial Natural Products and Biosynthesis (6 papers). Xingkang Wu is often cited by papers focused on Cancer therapeutics and mechanisms (9 papers), Bioactive Compounds and Antitumor Agents (7 papers) and Microbial Natural Products and Biosynthesis (6 papers). Xingkang Wu collaborates with scholars based in China. Xingkang Wu's co-authors include Yuemao Shen, Xuemei Qin, Chunhua Lu, Guanhua Du, Caixia Yin, Kaiqing Ma, Juanli Zhang, Zhenyu Li, Fangjun Huo and Fangqin Cheng and has published in prestigious journals such as Angewandte Chemie International Edition, Biochemical and Biophysical Research Communications and International Journal of Molecular Sciences.

In The Last Decade

Xingkang Wu

37 papers receiving 440 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xingkang Wu China 15 257 102 54 51 39 40 444
Chiara Cassiano Italy 13 190 0.7× 69 0.7× 63 1.2× 53 1.0× 18 0.5× 32 427
Raj Kumar Mongre South Korea 16 339 1.3× 96 0.9× 110 2.0× 38 0.7× 26 0.7× 36 737
Quoc‐Thai Nguyen Vietnam 14 248 1.0× 57 0.6× 41 0.8× 16 0.3× 29 0.7× 29 413
Leixiang Yang China 16 340 1.3× 54 0.5× 118 2.2× 34 0.7× 38 1.0× 31 621
Veronika Hanušová Czechia 16 406 1.6× 54 0.5× 79 1.5× 31 0.6× 73 1.9× 28 769
Shengrong Li China 15 344 1.3× 85 0.8× 125 2.3× 25 0.5× 29 0.7× 58 597
Dong‐Rong Zhu China 15 299 1.2× 46 0.5× 47 0.9× 21 0.4× 37 0.9× 38 459
Da‐Song Yang China 17 391 1.5× 109 1.1× 59 1.1× 36 0.7× 73 1.9× 36 630
Mona N. Oliveira Brazil 12 220 0.9× 55 0.5× 24 0.4× 44 0.9× 31 0.8× 20 506
Fenghua Kang China 13 308 1.2× 118 1.2× 138 2.6× 25 0.5× 37 0.9× 35 547

Countries citing papers authored by Xingkang Wu

Since Specialization
Citations

This map shows the geographic impact of Xingkang Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xingkang Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xingkang Wu more than expected).

Fields of papers citing papers by Xingkang Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xingkang Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xingkang Wu. The network helps show where Xingkang Wu may publish in the future.

Co-authorship network of co-authors of Xingkang Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Xingkang Wu. A scholar is included among the top collaborators of Xingkang Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xingkang Wu. Xingkang Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Xingkang, et al.. (2025). CDIS V1.0: A program for non-targeted rapid identification of cyclic dipeptides. Journal of Chromatography A. 1761. 466402–466402.
2.
Wu, Xingkang, et al.. (2025). Chemical Change of Velvet Antler After Vinegar Processing Was Related With the Increased Fecundity in Drosophila melanogaster. Biomedical Chromatography. 39(4). e70045–e70045. 1 indexed citations
3.
Wu, Xingkang, et al.. (2024). Discovery of Aloperine as a Potential Antineoplastic Agent for Cholangiocarcinoma Harboring Mutant IDH1. International Journal of Molecular Sciences. 25(17). 9226–9226. 1 indexed citations
4.
5.
Yang, He, et al.. (2024). A thiol-triggered croconaine–chromene integration to induce ferroptosis and photothermal synergistic efficient tumor ablation. Chemical Science. 15(36). 14924–14930. 6 indexed citations
6.
Li, Shi-Fei, Xiuyi Wang, Yuqin Yang, Xingkang Wu, & Liwei Zhang. (2023). Discovering the Mechanisms of Oleodaphnone as a Potential HIV Latency-Reversing Agent by Transcriptome Profiling. International Journal of Molecular Sciences. 24(8). 7357–7357. 5 indexed citations
7.
Ma, Kaiqing, He Yang, Xingkang Wu, et al.. (2023). An Activatable NIR Fluorescent Probe for NAD(P)H and Its Application to the Real‐Time Monitoring of p53 Abnormalities In Vivo. Angewandte Chemie. 135(19). 3 indexed citations
8.
Wu, Xingkang, et al.. (2023). A Route for Investigating Psoriasis: From the Perspective of the Pathological Mechanisms and Therapeutic Strategies of Cancer. International Journal of Molecular Sciences. 24(18). 14390–14390. 9 indexed citations
9.
Ma, Kaiqing, He Yang, Xingkang Wu, et al.. (2023). An Activatable NIR Fluorescent Probe for NAD(P)H and Its Application to the Real‐Time Monitoring of p53 Abnormalities In Vivo. Angewandte Chemie International Edition. 62(19). e202301518–e202301518. 33 indexed citations
10.
11.
Li, Shi-Fei, Liang Xue, Xingkang Wu, Xiang Gao, & Liwei Zhang. (2021). Discovering the Mechanisms of Wikstroelide E as a Potential HIV-Latency-Reversing Agent by Transcriptome Profiling. Journal of Natural Products. 84(4). 1022–1033. 15 indexed citations
12.
Yue, Yongkang, Tingting Zhao, Yuting Wang, et al.. (2021). HSA-Lys-161 covalent bound fluorescent dye for in vivo blood drug dynamic imaging and tumor mapping. Chemical Science. 13(1). 218–224. 26 indexed citations
13.
Li, Zhenyu, Xingkang Wu, Lejiao Jia, et al.. (2020). Design and synthesis of novel 2-arylbenzimidazoles as selective mutant isocitrate dehydrogenase 2 R140Q inhibitors. Bioorganic & Medicinal Chemistry Letters. 30(9). 127070–127070. 7 indexed citations
14.
Wu, Xingkang & Yuemao Shen. (2018). PMN inhibits colorectal cancer cells through inducing mitotic arrest and p53-dependent apoptosis via the inhibition of tubulin polymerization. Biochemical and Biophysical Research Communications. 499(4). 927–933. 8 indexed citations
15.
Wu, Xingkang, Zhenyu Li, & Yuemao Shen. (2018). The small molecule CS1 inhibits mitosis and sister chromatid resolution in HeLa cells. Biochimica et Biophysica Acta (BBA) - General Subjects. 1862(5). 1134–1147. 2 indexed citations
16.
17.
Hao, Huilin, Xingkang Wu, Zhenyu Li, et al.. (2016). Design and synthesis of N-(5-chloro-2,4-dihydroxybenzoyl)-(R)-1,2,3,4-tetrahydroisoquinoline-3-carboxamides as novel Hsp90 inhibitors. European Journal of Medicinal Chemistry. 121. 272–282. 18 indexed citations
18.
Li, Zhenyu, Lejiao Jia, Jifeng Wang, et al.. (2014). Design, synthesis and biological evaluation of 17-arylmethylamine-17-demethoxygeldanamycin derivatives as potent Hsp90 inhibitors. European Journal of Medicinal Chemistry. 85. 359–370. 20 indexed citations
19.
Li, Zhenyu, Lejiao Jia, Jifeng Wang, et al.. (2014). Discovery of diamine-linked 17-aroylamido-17-demethoxygeldanamycins as potent Hsp90 inhibitors. European Journal of Medicinal Chemistry. 87. 346–363. 16 indexed citations
20.
Li, Zhenyu, Lejiao Jia, Jifeng Wang, et al.. (2014). Discovery of Novel 17‐Phenylethylaminegeldanamycin Derivatives as Potent Hsp90 Inhibitors. Chemical Biology & Drug Design. 85(2). 181–188. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chiara Cassiano Breakdown of academic impact, for papers by Raj Kumar Mongre Breakdown of academic impact, for papers by Quoc‐Thai Nguyen Breakdown of academic impact, for papers by Leixiang Yang Breakdown of academic impact, for papers by Veronika Hanušová Breakdown of academic impact, for papers by Shengrong Li Breakdown of academic impact, for papers by Dong‐Rong Zhu Breakdown of academic impact, for papers by Da‐Song Yang Breakdown of academic impact, for papers by Mona N. Oliveira Breakdown of academic impact, for papers by Fenghua Kang
Rankless by CCL
2026